Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA252222
NIGMS NIH HHS
Grant: T32 GM007491
Intramural NIH HHS
Grant: ZIA BC011823
NCI NIH HHS
Grant: R35 CA253127
National Institutes of Health
Grant: 1ZIABC011823-04
Development of Novel Therapies for Acute Lymphoblastic Leukemia
National Institutes of Health
Grant: 5T32GM007491-46
Training Program in Cellular and Molecular Biology and Genetics
FWCI
3.60
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals